WO2000034335A3 - 'death domain' containing receptors - Google Patents

'death domain' containing receptors Download PDF

Info

Publication number
WO2000034335A3
WO2000034335A3 PCT/US1999/026035 US9926035W WO0034335A3 WO 2000034335 A3 WO2000034335 A3 WO 2000034335A3 US 9926035 W US9926035 W US 9926035W WO 0034335 A3 WO0034335 A3 WO 0034335A3
Authority
WO
WIPO (PCT)
Prior art keywords
death domain
containing receptors
reagents
polypeptides
nucleic acids
Prior art date
Application number
PCT/US1999/026035
Other languages
French (fr)
Other versions
WO2000034335A2 (en
Inventor
Clement Leong
Joseph H Phillips
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU20218/00A priority Critical patent/AU2021800A/en
Publication of WO2000034335A2 publication Critical patent/WO2000034335A2/en
Publication of WO2000034335A3 publication Critical patent/WO2000034335A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Purified genes from a mammalian virus, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding the polypeptides are provided. Methods of using said reagents and diagnostic kits are also provided.
PCT/US1999/026035 1998-12-04 1999-12-03 'death domain' containing receptors WO2000034335A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU20218/00A AU2021800A (en) 1998-12-04 1999-12-03 Mammalian genes; related reagents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20501898A 1998-12-04 1998-12-04
US09/205,018 1998-12-04

Publications (2)

Publication Number Publication Date
WO2000034335A2 WO2000034335A2 (en) 2000-06-15
WO2000034335A3 true WO2000034335A3 (en) 2000-08-10

Family

ID=22760451

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/026035 WO2000034335A2 (en) 1998-12-04 1999-12-03 'death domain' containing receptors

Country Status (2)

Country Link
AU (1) AU2021800A (en)
WO (1) WO2000034335A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506569B1 (en) 1997-05-30 2003-01-14 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR10
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
CN1980957A (en) 2004-03-23 2007-06-13 比奥根艾迪克Ma公司 Receptor coupling agents and therapeutic uses thereof
GB0818649D0 (en) * 2008-10-10 2008-11-19 Nat Univ Ireland Treatment of proliferative disorders with trail

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030387A1 (en) * 1995-03-31 1996-10-03 Aviron Novel human cytomegalovirus dna sequences

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030387A1 (en) * 1995-03-31 1996-10-03 Aviron Novel human cytomegalovirus dna sequences

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHA T.A. ET AL.: "Human Cytomegalovirus Clinical Isolates Carry at Least 19 Genes Not Found in Laboratory Strains", JOURNAL OF VIROLOGY, vol. 70, no. 1, 1996, pages 78 - 83, XP002137489 *
CHA T.A. ET AL.: "Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains; human cytomegalovirus Toledo strain UL/b' region", EMBL DATABASE ENTRY HC33331; ACCESSION NO. U33331, 29 January 1996 (1996-01-29), XP002137490 *
LURAIN N.S. ET AL.: "Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates", JOURNAL OF VIROLOGY, vol. 73, no. 12, December 1999 (1999-12-01), pages 10040 - 10050, XP000906955 *
LURAIN N.S. ET AL.: "Human herpesvirus 5 isolate PT026UL144 UL144 protein (UL144) gene, complete cds.", EMBL DATABASE ENTRY AF085001; ACCESION NO. AF085001, 21 November 1999 (1999-11-21), XP002137491 *
MEINL E ET AL: "Anti-apoptotic strategies of lymphotropic viruses", IMMUNOLOGY TODAY, vol. 19, no. 10, 1 October 1998 (1998-10-01), pages 474 - 479, XP004142764, ISSN: 0167-5699 *

Also Published As

Publication number Publication date
WO2000034335A2 (en) 2000-06-15
AU2021800A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
CA2263129A1 (en) Mammalian cell surface antigens; related reagents
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
MY157028A (en) Mammalian cytokine, related reagents
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
WO1997021812A3 (en) Mammalian chemokine ccf8 and chemokine receptor cckr3
LU91756I2 (en) denosumab
WO1998001557A3 (en) Mammalian chemokine reagents
EP1980573A3 (en) Isolated dendritic cell membrane protein genes
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
EP1897949A3 (en) Human interleukin-B50. Therapeutic uses
WO1998024906A3 (en) Isolated mammalian monocyte cell genes; related reagents
WO1998011226A3 (en) Mammalian chemokines, related reagents
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
WO1999003993A3 (en) Suppressors of cytokine signaling; related reagents
AU1825097A (en) Mammalian cx3c chemokine genes
WO1998039421A3 (en) Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
WO1998023750A3 (en) Mammalian chemokines
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
WO2000034335A3 (en) 'death domain' containing receptors
WO2003020005A3 (en) Lp mammalian proteins; related reagents
AU1695595A (en) Mammalian thymokine genes
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO2002074906A3 (en) Lp mammalian proteins; related reagents
WO2003022992A3 (en) Mammalian genes; related reagents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase